VECTURA GROUP PLC

Vectura Group PLC specializes in benchtop therapeutic agent nebulizers, specifically designed for mobile use. These devices, like the FOX MOBILE model, are intended to deliver aerosolized medications to patients in outpatient or home care settings. The focus is on portable solutions for respiratory therapy.

Vectura Group PLC is headquartered in the United States. The company’s location influences its regulatory compliance, particularly with U.S. medical device standards and reporting requirements.

The devices produced by Vectura Group PLC, such as the FOX MOBILE nebulizer, are classified as Class II medical devices. This classification typically means they pose moderate risk and require special controls to ensure safety and effectiveness, though they do not require pre-market approval like higher-risk Class III devices.

Yes, Vectura Group PLC’s devices, including the FOX MOBILE nebulizer, are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices in the U.S. market, ensuring transparency and traceability for healthcare providers and regulators.